Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells
- 1 June 2011
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 342 (1-2), 20-31
- https://doi.org/10.1016/j.mce.2011.05.023
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Transcription factor co‐repressors in cancer biology: roles and targetingInternational Journal of Cancer, 2010
- Genome-wide mechanisms of nuclear receptor actionTrends in Endocrinology & Metabolism, 2010
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate CancerCell, 2009
- Eloquent silence: developmental functions of Class I histone deacetylasesCurrent Opinion in Genetics & Development, 2008
- Cracking the coregulator codesCurrent Opinion in Cell Biology, 2008
- Androgen receptor variants and prostate cancer in humanized AR miceThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- The Androgen Receptor T877A Mutant Recruits LXXLL and FXXLF Peptides Differently than Wild-Type Androgen Receptor in a Time-Resolved Fluorescence Resonance Energy Transfer AssayBiochemistry, 2006
- Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1Cell, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995